Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Ramoni

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Clinical Investigation|April 7, 2025
The role of artificial intelligence in cardiovascular research: Fear less and live bolderAlessandro Scuricini, Davide Ramoni, Luca Liberale, et al.
Polish Archives of Internal Medicine|July 15, 2026
Biomarkers in predicting mortality in hemodialysis patients: recent advancesDavide Ramoni, Alessandro Scuricini, Luca Liberale, et al.
Current Atherosclerosis Reports|March 22, 2025
Inflammation-Driven Plaque Erosion in Atherosclerosis: A Focus on Complement System PathwaysDavide Ramoni, Federico Carbone, Simon Kraler, et al.
European Journal of Internal Medicine|July 24, 2024
Artificial intelligence in scientific medical writing: Legitimate and deceptive uses and ethical concernsDavide Ramoni, Cosimo Sgura, Luca Liberale, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 25, 2024
Baseline urinary osteopontin levels are associated with the improvement of metabolic syndromeMargherita Moriero, Daniela Verzola, Maria Bertolotto, et al.
Acta Anaesthesiologica Scandinavica|September 2, 2022
Markers of neutrophil mediated inflammation associate with disturbed continuous electroencephalogram after out of hospital cardiac arrestPirkka T Pekkarinen, Federico Carbone, Silvia Minetti, et al.
Lung|March 14, 2024
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung CancerDavide Ramoni, Simona Coco, Giovanni Rossi, et al.
European Journal of Internal Medicine|July 17, 2024
Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patientsLuca Liberale, Claudia Torino, Patrizia Pizzini, et al.
Biomedicines|November 27, 2024
Osteopontin and Clinical Outcomes in Hemodialysis PatientsClaudia Torino, Federico Carbone, Patrizia Pizzini, et al.
European Journal of Clinical Investigation|May 11, 2024
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patientsClaudia Torino, Federico Carbone, Patrizia Pizzini, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Clinical Investigation|April 7, 2025
The role of artificial intelligence in cardiovascular research: Fear less and live bolderAlessandro Scuricini, Davide Ramoni, Luca Liberale, et al.
Polish Archives of Internal Medicine|July 15, 2026
Biomarkers in predicting mortality in hemodialysis patients: recent advancesDavide Ramoni, Alessandro Scuricini, Luca Liberale, et al.
Current Atherosclerosis Reports|March 22, 2025
Inflammation-Driven Plaque Erosion in Atherosclerosis: A Focus on Complement System PathwaysDavide Ramoni, Federico Carbone, Simon Kraler, et al.
European Journal of Internal Medicine|July 24, 2024
Artificial intelligence in scientific medical writing: Legitimate and deceptive uses and ethical concernsDavide Ramoni, Cosimo Sgura, Luca Liberale, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 25, 2024
Baseline urinary osteopontin levels are associated with the improvement of metabolic syndromeMargherita Moriero, Daniela Verzola, Maria Bertolotto, et al.
Acta Anaesthesiologica Scandinavica|September 2, 2022
Markers of neutrophil mediated inflammation associate with disturbed continuous electroencephalogram after out of hospital cardiac arrestPirkka T Pekkarinen, Federico Carbone, Silvia Minetti, et al.
Lung|March 14, 2024
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung CancerDavide Ramoni, Simona Coco, Giovanni Rossi, et al.
European Journal of Internal Medicine|July 17, 2024
Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patientsLuca Liberale, Claudia Torino, Patrizia Pizzini, et al.
Biomedicines|November 27, 2024
Osteopontin and Clinical Outcomes in Hemodialysis PatientsClaudia Torino, Federico Carbone, Patrizia Pizzini, et al.
European Journal of Clinical Investigation|May 11, 2024
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patientsClaudia Torino, Federico Carbone, Patrizia Pizzini, et al.
Pageof 3